x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934.
|
¨
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
Delaware
|
|
36-3688459
|
(State
or Other Jurisdiction of Incorporation
or Organization)
|
|
(I.R.S.
EmployerIdentification
No.)
|
1001
Cambridge Drive, Elk Grove Village, Illinois
|
|
60007
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
|
|
|
|
Large
accelerated filer ¨
|
|
Accelerated
filer ¨
|
|
Non-accelerated
filer x
|
|
|
|
Class
|
|
Outstanding
at October 30, 2007
|
Common
Stock, par value $0.001 per share
|
|
200,633,315
|
|
|
|
|
|
|
i
|
|||
|
|
|||
|
||||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
||||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
|
September
30,
|
December
31,
|
||||||
|
2007
|
2006
|
||||||
|
(unaudited)
|
|
||||||
Assets:
|
|
|
||||||
Current
Assets:
|
|
|
||||||
Cash
and equivalents
|
$ |
2,782,761
|
$ |
2,886,476
|
||||
Inventory
|
3,820,067
|
6,368,599
|
||||||
Accounts
receivable, net
|
889,908
|
2,554,716
|
||||||
Prepaid
expenses and other
|
80,485
|
168,741
|
||||||
Total
current assets
|
7,573,221
|
11,978,532
|
||||||
Property
and equipment
|
1,407,530
|
1,334,203
|
||||||
Less:
accumulated depreciation
|
(909,363 | ) | (811,167 | ) | ||||
Net
property and equipment
|
498,167
|
523,036
|
||||||
Restricted
certificates of deposit
|
170,648
|
162,440
|
||||||
Goodwill
|
13,370,000
|
13,370,000
|
||||||
Intangible
assets, net
|
848,617
|
841,187
|
||||||
Total
Assets
|
$ |
22,460,653
|
$ |
26,875,195
|
||||
Liabilities
and Stockholders' Equity:
|
||||||||
Current
Liabilities:
|
||||||||
Accounts
Payable
|
$ |
224,087
|
$ |
1,172,844
|
||||
Inventory-related
material purchase accrual
|
84,607
|
328,663
|
||||||
Employee-related
accrued liability
|
184,730
|
284,653
|
||||||
Accrued
professional services
|
46,000
|
93,000
|
||||||
Other
accrued liabilities and current deferred revenue
|
217,342
|
225,724
|
||||||
Current
Portion of LT Debt, including related interest, with related
parties
|
-
|
11,295,957
|
||||||
Total
Current Liabilities
|
756,766
|
13,400,841
|
||||||
Deferred
facility reimbursement
|
91,250
|
102,500
|
||||||
Deferred
revenue - non current
|
128,040
|
75,900
|
||||||
Notes
Payable, with related parties
|
15,363,070
|
5,000,000
|
||||||
Accrued
interest payable, with related parties
|
324,150
|
131,762
|
||||||
Stockholders'
equity:
|
||||||||
Preferred
stock; 300,000 shares authorized; No shares issued and
outstanding
|
||||||||
at September 30, 2007 and December 31, 2006
|
-
|
-
|
||||||
Common
stock ($.001 par value); 250,000,000 shares authorized;
200,508,315
|
||||||||
and 189,622,133 shares issued and outstanding at September 30, 2007
and
|
||||||||
December 31, 2006, respectively
|
200,508
|
189,622
|
||||||
Treasury
Stock
|
(64,260 | ) |
-
|
|||||
Additional
paid-in capital (net of unearned compensation)
|
175,086,385
|
172,379,842
|
||||||
Accumulated
deficit
|
(169,425,256 | ) | (164,405,272 | ) | ||||
Total
Shareholders' Equity
|
5,797,377
|
8,164,192
|
||||||
Total
Liabilities and Shareholders' Equity
|
$ |
22,460,653
|
$ |
26,875,195
|
NOTE:
The condensed consolidated balance sheet as of December 31,2006 has
been
derived from the audited financial statements for that date, but
does not
include all of the information and accompanying notes required by
accounting principles generally accepted in the United States of
America
for complete financial statements.
|
|
See
the accompanying Notes which are an integral part of the Condensed
Consolidated Financial Statements.
|
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||||
|
September
30,
|
September
30,
|
||||||||||||||
|
2007
|
2006
|
2007
|
2006
|
||||||||||||
Net
sales
|
$ |
1,924,401
|
$ |
6,433,439
|
$ |
6,300,357
|
$ |
11,205,308
|
||||||||
Costs
and Expenses:
|
||||||||||||||||
Cost
of sales
|
1,220,913
|
3,850,012
|
3,633,283
|
6,739,266
|
||||||||||||
Research
and development
|
721,241
|
452,435
|
2,004,003
|
1,390,374
|
||||||||||||
Selling
and marketing
|
554,494
|
989,329
|
1,808,800
|
2,472,426
|
||||||||||||
General
and administrative
|
1,003,762
|
1,093,684
|
3,185,141
|
3,152,764
|
||||||||||||
Total
Costs and Expenses
|
3,500,410
|
6,385,460
|
10,631,227
|
13,754,830
|
||||||||||||
|
||||||||||||||||
Operating
(Loss) Income
|
(1,576,009 | ) |
47,979
|
(4,330,870 | ) | (2,549,522 | ) | |||||||||
Other
Income (Expense):
|
||||||||||||||||
Interest
income
|
34,182
|
45,872
|
70,387
|
97,885
|
||||||||||||
Interest
(expense)
|
(248,712 | ) | (261,007 | ) | (759,501 | ) | (646,344 | ) | ||||||||
Other
income (expense), net
|
(214,530 | ) | (215,135 | ) | (689,114 | ) | (548,459 | ) | ||||||||
|
||||||||||||||||
Net
Loss
|
$ | (1,790,539 | ) | $ | (167,156 | ) | $ | (5,019,984 | ) | $ | (3,097,981 | ) | ||||
|
||||||||||||||||
Basic
and diluted loss per share
|
$ | (0.01 | ) | $ | (0.00 | ) | $ | (0.03 | ) | $ | (0.02 | ) | ||||
|
||||||||||||||||
Weighted
average number of common
|
||||||||||||||||
shares
outstanding
|
200,154,000
|
186,105,594
|
193,433,000
|
184,705,066
|
|
|
Common
|
|
Common
|
|
Treasury
|
|
Additional
|
|
Accumulated
|
|
|
|
|
|
Stock
|
|
Stock
|
|
Stock
|
|
Paid-In
|
|
Deficit
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Amount
|
|
Capital
|
|
|
|
Total
|
|
Balance
as of December 31, 2006
|
|
189,622,133
|
$
|
189,622
|
$
|
|
$
|
172,379,842
|
$
|
(164,405,272)
|
$
|
8,164,192
|
|
Exercise
of stock options and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
vesting of restricted shares
|
|
2,892,849
|
|
2,893
|
|
|
|
(2,893)
|
|
|
|
-
|
|
1.5M
accrued interest converted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
to
equity
|
|
8,333,333
|
|
8,333
|
|
|
|
1,491,667
|
|
|
|
1,500,000
|
|
Treasury
stock
|
|
(340,000)
|
|
(340)
|
|
(64,260)
|
|
|
|
|
|
(64,600)
|
|
Equity
compensation expense
|
|
|
|
|
|
|
|
1,217,769
|
|
|
|
1,217,769
|
|
Net
loss
|
|
|
|
|
|
|
|
|
|
(5,019,984)
|
|
(5,019,984)
|
|
Balance
at September 30, 2007
|
|
200,508,315
|
$
|
200,508
|
$
|
(64,260)
|
$
|
175,086,385
|
$
|
(169,425,256)
|
$
|
5,797,377
|
|
|
Nine
Months Ended
|
Nine
Months Ended
|
||||||
|
September
30, 2007
|
September
30, 2006
|
||||||
OPERATING
ACTIVITIES
|
|
|
||||||
Net
loss
|
$ | (5,019,984 | ) | $ | (3,097,981 | ) | ||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
138,488
|
105,990
|
||||||
Non-cash
compensation charges
|
1,217,769
|
1,026,423
|
||||||
Changes
in operating assets and liabilities
|
3,750,119
|
(2,535,432 | ) | |||||
Net
cash provided by (used in) operating activities
|
86,392
|
(4,501,000 | ) | |||||
INVESTING
ACTIVITIES
|
||||||||
(Increase)/Decrease
in restricted certificates of deposit
|
(8,208 | ) |
80,414
|
|||||
Payment
of patent costs
|
(47,722 | ) | (32,547 | ) | ||||
Acquisition
of property and equipment, net
|
(69,577 | ) | (120,939 | ) | ||||
Net
cash used in investing activities
|
(125,507 | ) | (73,072 | ) | ||||
FINANCING
ACTIVITIES
|
||||||||
Proceeds
from Section 16b recovery
|
-
|
3,124
|
||||||
Proceeds
from debt issuance
|
-
|
5,000,000
|
||||||
Exercise
of stock options/vesting of restricted stock grants
|
-
|
257,900
|
||||||
Treasury
stock purchased
|
(64,600 | ) |
-
|
|||||
Net
cash provided by (used in) financing activities
|
(64,600 | ) |
5,261,024
|
|||||
|
||||||||
(Decrease)/Increase
in cash and cash equivalents
|
(103,715 | ) |
686,952
|
|||||
Cash
and cash equivalents at beginning of period
|
2,886,476
|
3,486,430
|
||||||
Cash
and cash equivalents at end of period
|
$ |
2,782,761
|
$ |
4,173,382
|
|
September
30, 2007
|
December
31, 2006
|
||||||
Raw
materials
|
$ |
1,614,000
|
$ |
2,675,000
|
||||
Work
in process
|
1,079,000
|
2,332,000
|
||||||
Finished
product
|
1,127,000
|
1,362,000
|
||||||
Total
|
$ |
3,820,000
|
$ |
6,369,000
|
|
|
Weighted
|
||||||
|
|
Average
Grant Date
|
||||||
|
Shares
|
Fair
Value (per share)
|
||||||
|
|
|
||||||
Outstanding,
December 31, 2006
|
8,714,000
|
0.35
|
||||||
Granted
|
3,577,000
|
0.25
|
||||||
Forfeited
or canceled
|
(915,000 | ) |
0.33
|
|||||
Vested
|
(2,893,000 | ) |
0.34
|
|||||
Outstanding,
September 30, 2007
|
8,483,000
|
0.31
|
Contractual
Obligations
|
Payments
Due by Period
|
|
|
|
|
|
|
|
|||
|
|
|
|
Less
than 1
|
|
|
|
|
|
More
than
|
|
Year
|
|
Total
|
|
Year
|
|
1-3
Years
|
|
3-5
Years
|
|
5
Years
|
|
Long
Term Debt Obligations
|
$
|
17,837,000
|
$
|
-
|
$
|
17,837,000
|
$
|
-
|
$
|
-
|
|
Operating
Lease Obligations
|
$
|
1,509,000
|
$
|
204,000
|
$
|
417,000
|
$
|
434,000
|
$
|
454,000
|
|
Total
|
$
|
19,346,000
|
$
|
204,000
|
$
|
18,254,000
|
$
|
434,000
|
$
|
454,000
|
|
|
(a)
|
An
evaluation was performed under the supervision and with the participation
of the Company’s management, including its Chief Executive Officer, or
CEO, and Chief Financial Officer, or CFO, of the effectiveness of
the
Company’s disclosure controls and procedures, as such term is defined
under Rule 13a-15(e) promulgated under the Securities Exchange Act
of
1934, as amended (the “Exchange Act”) as of September 30, 2007. Based
on that evaluation, the Company’s management, including the CEO and CFO,
concluded that the Company’s disclosure controls and procedures are
effective to ensure that information required to be disclosed by
the
Company in reports that it files or submits under the Exchange Act,
is
recorded, processed, summarized and reported as specified in Securities
and Exchange Commission rules and forms.
|
|
(b)
|
There
were no changes in the Company’s internal control over financial reporting
identified in connection with the evaluation of such controls that
occurred during the Company’s most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect,
the
Company’s internal control over financial
reporting.
|
|
•
|
|
the
market price of our common stock might decline to the extent that
the
current market price reflects a market assumption that the merger
will be
completed; and
|
|
•
|
|
our
unreimbursed costs incurred related to the merger must be paid
even if the
merger is not completed.
|
Exhibit
Number
|
|
Description
of Exhibit
|
|
10.1
|
Amendment
to Loan Documents dated June 26, 2007 between ISCO International,
Inc.,
Manchester Securities Corporation, Alexander Finance, L.P., ISCO
International, Inc. , Spectral Solutions, Inc. and Illinois Superconductor
Corporation
|
||
10.2
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Manchester Securities Corporation, dated
June 26,
2007, in the amount of $2,520,441.39
|
||
10.3
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Manchester Securities Corporation, dated
June 26,
2007, in the amount of $1,522,687.06
|
||
10.4
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Manchester Securities Corporation, dated
June 26,
2007, in the amount of $147,240.00
|
||
10.5
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Manchester Securities Corporation, dated
June 26,
2007, in the amount of $1,121,625.00
|
||
10.6
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Alexander Finance, LLC, dated June 26,
2007, in
the amount of $1,622,405.00
|
||
10.7
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Alexander Finance, LLC, dated June 26,
2007, in
the amount of $1,314,300.00
|
||
10.8
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Alexander Finance, LLC, dated June 26,
2007, in
the amount of $1,375,000.00
|
||
10.9
|
Amended
and Restated 7% Senior Secured Convertible Note by and between
ISCO
International, Inc. and Alexander Finance, LLC, dated June 26,
2007, in
the amount of $550,000.00
|
||
10.10
|
Registration
Rights Agreement dated June 26, 2007, by and among ISCO International,
Inc., Manchester Securities Corp. and Alexander Finance,
L.P.
|
||
31.1
|
Certification
by Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a)
as
adopted pursuant to Section 302 of the Sarbanes Oxley Act of
2002.
|
||
31.2
|
Certification
by Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a)
as
adopted pursuant to Section 302 of the Sarbanes Oxley Act of
2002.
|
||
|
|
||
32.1
|
|
Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of
the Sarbanes-Oxley Act of
2002.
|
|
|
|
|
ISCO
International, Inc.
|
|||
|
|
||
By:
|
|
/s/
Ralph Pini
Ralph
Pini
Interim
Chief Executive Officer
(Principal
Executive Officer)
|
|
|
|
||
By:
|
|
/s/
Frank Cesario
Frank
Cesario
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
|